Digital Pharma's quantum leap: How AI is redefining media measuremen... Welcome to the era where the convergence of quantum computing and artificial intelligence isn't just an advantage, it's the imperative.
Sales & Marketing Optimising customer experience in global medical information... Technology and AI may come to bear in establishing global MI services.
Sales & Marketing Optimising customer experience in global medical information... In MI, it is increasingly important to find methodologies to increase global efficiencies while optimising the customer experience.
Digital Creating a winning playbook for consistent digital product s... While pharma companies are embracing the transition to digital, and investing significantly in their new products, only 4% of senior executives agree that their digital product launches are
Digital Can creative analytics solve your D2C paid search headache? Digitalisation has forever changed how we engage with healthcare.
R&D Ensuring R&D investments deliver maximum potential: Notable ... As the drug development landscape becomes more complex, pharmaceutical and biotech companies understand their business strategies have to evolve.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.